Alfred D. Kingsley - 22 Dec 2022 Form 4 Insider Report for Oncocyte Corp (OCX)

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OCX	Common Stock, no par value	Purchase	$7,125	+25,000	+6%	$0.2850	439,111	22 Dec 2022	Direct
holding	OCX	Common Stock, no par value						75,345	22 Dec 2022	See Footnote	F1
holding	OCX	Common Stock, no par value						18,767	22 Dec 2022	See Footnote	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The shares of common stock are held by Greenbelt Corp. The Reporting Person is the President of Greenbelt Corp. and in such capacity has the right to vote and dispose of the securities held by such entity.
F2	The shares of common stock are held by Greenway Partners, LP. The Reporting Person is the General Partner of Greenway Partners, LP and in such capacity has the right to vote and dispose of the securities held by such entity.